Agenus

+$0.00 (+0.13%) As of 1:46 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Agenus and other ETFs, options, and stocks.

About AGEN

Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, and AGEN1777.

CEO
Garo H. Armen
Employees
359
Headquarters
Lexington, Massachusetts
Founded
1994

AGEN Key Statistics

Market Cap
889.33M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.61M
High Today
$3.85
Low Today
$3.77
Open Price
$3.80
Volume
223.30K
52 Week High
$6.79
52 Week Low
$2.50

AGEN Earnings

-$0.37
-$0.25
-$0.12
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 9, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure